fibryga
octapharma brasil ltda - fibrinogÊnio - fracoes do sangue ou plasma exceto gamaglobulina
haemocomplettan p
csl behring comÉrcio de produtos farmacÊuticos ltda - fibrinogÊnio - fracoes do sangue ou plasma exceto gamaglobulina
capilarema
laboratÓrios baldacci ltda - aminaftona - antifibrinoliticos
clonidin
cristÁlia produtos quÍmicos farmacÊuticos ltda. - cloridrato de clonidina - analgesicos nao narcoticos
clize
halex istar indÚstria farmacÊutica sa - cloridrato de clonidina - analgesicos
cloridrato de clonidina
instituto biochimico indÚstria farmacÊutica ltda - cloridrato de clonidina - analgesicos nao narcoticos
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - agentes antineoplásicos - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
imcivree
rhythm pharmaceuticals netherlands b.v. - setmelanotide - obesidade - preparados antiobesidade, excl. produtos dietéticos - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.
intuniv
takeda pharmaceuticals international ag ireland branch - cloridrato de guanfacina - transtorno de déficit de atenção com hiperatividade - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv deve ser utilizado como parte de um abrangente programa de tratamento de tdah, normalmente incluindo psicológicos, educacionais e sociais medidas.
vimco emulsão para injeção para ovelhas e cabras
laboratórios hipra - staphylococcus aureus inativado, estirpe sp140 cp**8 8.98 sacc - emulsão injetável - vacinas bacterianas inativadas (incluindo mycoplasma, toxóide e clamídia) - ovinos (ovelhas), cabra adulta